• President, Enzo Therapeutics, Inc., subsidiary of Enzo Biochem (NYSE: ENZ)
• President & CEO Sapphire Therapeutics, Inc.
• Vice President, Global Business Development & Licensing, Novartis
• Business Development, Knoll Pharmaceutical
• VP, Cardiovascular Business Unit (Angiomax®), The Medicines Company, Cambridge, MA
• Sales (RMA), product management (Tagamet®, Hycamtin®), new product development (Kytril®, Androderm®, Argatroban®); SmithKline Beecham Pharmaceuticals

14 years academic and consulting in clinical pharmacy, including faculty positions at

• New York Hospital–Cornell Medical Center
• University of California, San Francisco
• University of Pennsylvania
• University of Tennessee, Memphis